Aunt Minnie (1/10, Kim) reports that researchers have created a “3D-printed robot-guided device capable of facilitating MR-guided breast biopsy and improving the accuracy of breast cancer diagnosis.” The group includes Vincent Groenhuis, Françoise Siepel, PhD, and Stefano Stramigioli, PhD, from the Robotics and Mechatronics laboratory at the University of Twente in the Netherlands. The article says, “In a proof-of-concept study, the researchers found that the device was able to maneuver a needle toward target coordinates inside the breast with extreme precision on a single attempt.” The device is called Stormram 4 and it won the Surgical Robot Challenge at the 2017 Hamlyn Symposium in London, “a major event in the field of robotic surgery.”
TIME (1/8, Park) reports that research suggests “women who work the night shift have a 19% increased risk of developing cancer compared to women do not work at night.” The findings were published in Cancer Epidemiology, Biomarkers & Prevention. After analyzing data from 61 studies, researchers “found that women who worked night shifts for longer periods of time had a 41% higher risk of skin cancer, 32% higher risk of breast cancer and an 18% greater risk of digestive system cancers compared to women who did not work night shifts.” The data indicated that “the risk was highest among nurses who worked at night; their risk of developing breast cancer if they worked night shifts long term was 58% higher than nurses who didn’t have night shifts.”
HealthDay (1/8, Dallas) reports that the studies analyzed included “people from North America, Europe, Australia and Asia.” When the investigators “took into account for location, they found that only the night-shift workers from North America and Europe had a greater risk for breast cancer.” Medscape (1/8, Jenkins) also covers the story.
Aunt Minnie (1/4) reports a new study suggests that breast cancer screening protocol based only on a woman’s risk factors, rather than on age, could “result in delayed detection for many women.” The findings published in the American Journal of Roentgenology “suggest that a risk-based approach to screening, considered by some to be useful for alleviating the so-called harms of mammography and reducing healthcare costs, could be dangerous for many women at average risk of breast cancer, wrote a team led by Dr. Colleen Neal from the University of Michigan.” Dr. Neal and colleagues concluded, “Delaying initiation or decreasing the frequency of breast cancer screening for average-risk women could...sacrifice an important mortality reduction benefit.”
Aunt Minnie (1/2, Yee) reports that fewer than “20% of women in the Medicare population received digital breast tomosynthesis (DBT) exams in 2015, the first year of Medicare coverage for the technology, according to research presented at the recent RSNA 2017 meeting.” Presenter Dr. Gilda Boroumand from Thomas Jefferson University Hospital in Philadelphia explained in an interview, “Yes, fewer than 20% of breast cancer screening studies were performed with tomosynthesis in 2015, but that is still a large number considering the magnitude of effort and cost that is necessary for practices to acquire the technology.” Boroumand added, “The Medicare data are very useful. They confirm that tomosynthesis has crossed over from the experimental to the clinical realm and show that radiologists really have embraced this new technology.”
Aunt Minnie (12/15, Yee) reported that research suggests “many women don’t feel completely informed about their surgical options for breast cancer treatment.” The findings “suggest that women need access to consistent, reliable information about surgical breast cancer treatment in a variety of formats, wrote” the researchers. The research was published online in the Journal of the American College of Surgeons.